![](https://elea.com/wp-content/uploads/Elefix.png)
Elefix
Therapeutic Area
Antineoplastic + Oncology
Active Ingredient
Eribulin Mesylate
Line
Oncology
Dosage forms
1 vial containing 0.44 mg/mL